cardiometabolic clinics glp-1 therapy near me Heart transplantation in the Era: Time to catch up? Invited commentary for “The association between glucagon-like peptide 1 receptor agonist and outcomes after heart transplant” New at Texas Cardiology Associates:

Lawrence Herman: Served on an advisory board for Novo Nordisk and is on the speakers bureau for Novo Nordisk

Results from clinical trials suggest that such drugs could have potential for the treatment of asthma, which is one of the most chronic inflammatory pulmonary diseases in the world and often linked to both type 2 diabetes and obesity (Wu, Stokes Peebles)

After a median follow-up time of 2.2 years (IQR: 1.42-3.06), 3 individuals were newly detected HDVAb-positive, representing an incidence rate of 3.69/1000 patient-years

Key Takeaways GLP-1 medications mimic natural hormones that help regulate appetite, insulin production, and blood sugar levels, making them effective for managing type 2 diabetes and supporting weight loss

None of the hospitalizations were due to dental issues